444 related articles for article (PubMed ID: 22971196)
1. Is the pain of topical photodynamic therapy with methyl aminolevulinate any different from that with 5-aminolaevulinic acid?
Ibbotson SH; Valentine R; Hearn R
Photodermatol Photoimmunol Photomed; 2012 Oct; 28(5):272-3. PubMed ID: 22971196
[TBL] [Abstract][Full Text] [Related]
2. Risk of acute postoperative hypertension after topical photodynamic therapy for non-melanoma skin cancer.
Borroni RG; Carugno A; Rivetti N; Arbustini E; Brazzelli V
Photodermatol Photoimmunol Photomed; 2013 Apr; 29(2):73-7. PubMed ID: 23458390
[TBL] [Abstract][Full Text] [Related]
3. Methyl-aminolevulinate photodynamic therapy for the treatment of actinic keratoses and non-melanoma skin cancers: a retrospective analysis of response in 462 patients.
Fai D; Arpaia N; Romano I; Vestita M; Cassano N; Vena GA
G Ital Dermatol Venereol; 2009 Jun; 144(3):281-5. PubMed ID: 19528909
[TBL] [Abstract][Full Text] [Related]
4. Methyl aminolevulinate: actinic keratoses and Bowen's disease.
Morton CA
Dermatol Clin; 2007 Jan; 25(1):81-7. PubMed ID: 17126745
[TBL] [Abstract][Full Text] [Related]
5. Similar effectiveness of methyl aminolevulinate and 5-aminolevulinate in topical photodynamic therapy for nodular basal cell carcinoma.
Kuijpers DI; Thissen MR; Thissen CA; Neumann MH
J Drugs Dermatol; 2006; 5(7):642-5. PubMed ID: 16865869
[TBL] [Abstract][Full Text] [Related]
6. The relationship between protoporphyrin IX photobleaching during real-time dermatological methyl-aminolevulinate photodynamic therapy (MAL-PDT) and subsequent clinical outcome.
Tyrrell JS; Campbell SM; Curnow A
Lasers Surg Med; 2010 Sep; 42(7):613-9. PubMed ID: 20806386
[TBL] [Abstract][Full Text] [Related]
7. Photodynamic therapy of non-melanoma skin cancer with methyl aminolaevulinate is associated with less pain than with aminolaevulinic acid.
Gaál M; Otrosinka S; Baltás E; Ocsai H; Oláh J; Kemény L; Gyulai R
Acta Derm Venereol; 2012 Mar; 92(2):173-5. PubMed ID: 22113788
[No Abstract] [Full Text] [Related]
8. Factors predicting pain and effect of oral analgesia in topical photodynamic therapy.
Hambly RA; Mansoor N; Quinlan C; Shah Z; Lenane P; Ralph N; Moloney FJ
Photodermatol Photoimmunol Photomed; 2017 May; 33(3):176-179. PubMed ID: 28196277
[No Abstract] [Full Text] [Related]
9. Photodynamic therapy with violet light and topical 6-aminolaevulinic acid in the treatment of actinic keratosis, Bowen's disease and basal cell carcinoma.
Dijkstra AT; Majoie IM; van Dongen JW; van Weelden H; van Vloten WA
J Eur Acad Dermatol Venereol; 2001 Nov; 15(6):550-4. PubMed ID: 11843215
[TBL] [Abstract][Full Text] [Related]
10. The France-PDT study: a national prospective observational cohort survey on the use of methyl-aminolevulinate photodynamic therapy in France, with up to 6-month follow-up.
Farhi D; Bedane C; Savary J; Basset-Seguin N
Eur J Dermatol; 2013; 23(1):68-76. PubMed ID: 23400280
[TBL] [Abstract][Full Text] [Related]
11. Topical aminolaevulinic acid- and aminolaevulinic acid methyl ester-based photodynamic therapy with red and violet light: influence of wavelength on pain and erythema.
Mikolajewska P; Iani V; Juzeniene A; Moan J
Br J Dermatol; 2009 Nov; 161(5):1173-9. PubMed ID: 19785604
[TBL] [Abstract][Full Text] [Related]
12. How we treat Bowen's disease with topical photodynamic therapy in Dundee.
Attili SK; Ibbotson SH
Photodiagnosis Photodyn Ther; 2009 Mar; 6(1):41-5. PubMed ID: 19447370
[TBL] [Abstract][Full Text] [Related]
13. A review of pain experienced during topical photodynamic therapy--our experience in Dundee.
Attili SK; Dawe R; Ibbotson S
Photodiagnosis Photodyn Ther; 2011 Mar; 8(1):53-7. PubMed ID: 21333935
[TBL] [Abstract][Full Text] [Related]
14. Treatment of superficial basal cell carcinoma by topical photodynamic therapy with fractionated 5-aminolaevulinic acid 20% vs. two-stage topical methyl aminolaevulinate: results of a randomized controlled trial.
Kessels JPHM; Kreukels H; Nelemans PJ; Roozeboom MH; van Pelt H; Mosterd K; de Haas ERM; Kelleners-Smeets NWJ
Br J Dermatol; 2018 May; 178(5):1056-1063. PubMed ID: 28886209
[TBL] [Abstract][Full Text] [Related]
15. A quantitative comparison of 5-aminolaevulinic acid- and methyl aminolevulinate-induced fluorescence, photobleaching and pain during photodynamic therapy.
Valentine RM; Ibbotson SH; Brown CT; Wood K; Moseley H
Photochem Photobiol; 2011; 87(1):242-9. PubMed ID: 21077899
[TBL] [Abstract][Full Text] [Related]
16. Treatment of Bowen's disease with photodynamic therapy. Observational study in 171 patients with 5-aminolaevulinic acid (BF-200 ALA) and methyl aminolaevulinate (MAL).
Alique-García S; Alique D; Company-Quiroga J; Sánchez A; Núñez AH; Borbujo J
Photodiagnosis Photodyn Ther; 2019 Dec; 28():192-194. PubMed ID: 31398515
[TBL] [Abstract][Full Text] [Related]
17. Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma: results of a multicenter randomized prospective trial.
Rhodes LE; de Rie M; Enström Y; Groves R; Morken T; Goulden V; Wong GA; Grob JJ; Varma S; Wolf P
Arch Dermatol; 2004 Jan; 140(1):17-23. PubMed ID: 14732655
[TBL] [Abstract][Full Text] [Related]
18. Randomized, double-blind, prospective study to compare topical 5-aminolaevulinic acid methylester with topical 5-aminolaevulinic acid photodynamic therapy for extensive scalp actinic keratosis.
Moloney FJ; Collins P
Br J Dermatol; 2007 Jul; 157(1):87-91. PubMed ID: 17501954
[TBL] [Abstract][Full Text] [Related]
19. Aminolevulinic acid photodynamic therapy for skin cancers.
Blume JE; Oseroff AR
Dermatol Clin; 2007 Jan; 25(1):5-14. PubMed ID: 17126737
[TBL] [Abstract][Full Text] [Related]
20. A retrospective review of pain control by a two-step irradiance schedule during topical ALA-photodynamic therapy of non-melanoma skin cancer.
Zeitouni NC; Paquette AD; Housel JP; Shi Y; Wilding GE; Foster TH; Henderson BW
Lasers Surg Med; 2013 Feb; 45(2):89-94. PubMed ID: 23390058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
